Contract Research Organization Market is predicted to be worth $ 76,457.4 million in 2023

Global Contract research organization (CRO) Market Information; By Segment (Drug Discovery, Clinical Development, Post Marketing Services); By Clinical Trial Phase (Preclinical Trials, Phase I, Phases II, Phases III and Phase IV); by End User (Pharmaceutical/ biotechnology Companies, Medical devices Companies, Academic Institutes) - Forecast to 2023

Market Highlights

Market research future has published a half cooked research report on Global Contract Research Organization (CRO) Market. The global contract research organization (CRO) market is growing at an average rate and is expected show the similar trend during forecast period.

Contract research organizations undertake research on a contract basis from their client. The rights to the work are owned ultimately by the clients who may not have the technical capabilities and capacities to perform the task on their own. Due to the large number of patents expiries, drug companies are under pressure to replace the revenue loss. The rising costs of drug development have put pressure on profit margins. On the other hand there has been an exponential growth in the skills of the contract research organizations. Thus contracting out has become an increasing attractive proposition for both clients and the contract research organization.

Request a Sample Report @

Major Market Players:

• Laboratory Corporation of America Holdings,
• QuintilesIMS,
• PAREXEL International Corporation,
• Pharmaceutical Product Development, LLC,
• INC Research LLC,
• PRA Health Sciences, Inc.,
• ICON plc.

Additionally many governments have increased funding for research and development to combat diseases such as cancer, Alzheimer's etc. Large tax deductions for research coupled with increasing partnerships is also a big driver for the CRO market.

The level of R&D outsourcing will expand significantly in preclinical & clinical segment. The highly specialized nature of the segment coupled with the increasing stringency of the regulations has led to the shift. The need to reduce the costs of the clinical studies especially the phase four studies is another reason for the need to contract out the service. The contract research organization is in a position to bundle many contracts which reduces the costs of the study due to economies of scale. Contracting out clinical tests also eliminates the need to maintain elaborate equipment and personnel’s by the client.

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Contract research organization (CRO) Market Research Report – Forecast to 2023.”

Report Details @

Another reason is the growing importance of the supply chains and partnerships for risk sharing and cost sharing. Thus contracting out is done for quality improvement, increasing efficiency, reducing time to market a new product etc. Thus maintaining competitive advantage in today’s cut throat market has become imperative. Increasing need for highly advanced products such as targeted therapies for cancer has led companies to take advantage of contracting out their specialized needs.


The global contract research organization (CRO) market is segmented on the basis of segment. Based on the segment, the market has been segmented as drug discovery, clinical development, and post marketing services. Based on the clinical trial phase, the market has been segmented as Phase I, Phases II, Phases III and Phase IV. Based on the End User, the market has been segmented as Pharmaceutical/ biotechnology Companies, Medical devices Companies, and Academic Institutes.

Make an Enquiry @

Table of Content
1 Report Prologue
1.1 Introduction
2 Market Introduction
2.1 Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology

Browse related Statistical Report

Europe Microfluidic Devices Market is projected to grow at a CAGR of 20.80% and is expected to reach US$ 5385.80 million by 2024. In Europe Microfluidic Devices Market, Germany accounted for the largest market share in 2015.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Office No. 524/528, Amanora Chambers Magarpatta Road, Hadapsar Pune -
Phone: +1 646 845 9312

Release ID: 217140